Maxime Bodinier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maxime Bodinier has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Karen Brengel-Pesce
Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France
2 shared publications- Anne Conrad
Hospices Civils de Lyon, Lyon, France
1 shared publication - Anne-Claire Lukaszewicz
Joint Research Unit HCL-bioMérieux, EA 7426 “Pathophysiology of Injury-Induced Immunosuppression”, Hospices Civils de Lyon-bioMérieux, Université Claude Bernard Lyon 1, 69003 Lyon, France
1 shared publication Claire Tardiveau
EA 7426 "Pathophysiology of Injury-Induced Immunosuppression" (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Joint Research Unit HCL-bioMérieux, Lyon 69003, France
1 shared publicationFabien Subtil
Biostatistics Department, Hospices Civils de Lyon, Lyon France, Lyon 1 University, Villeurbanne, France; CNRS, Biometrics and Evolutionary Biology Laboratory UMR, Villeurbanne, France
1 shared publication- Fabienne Venet
Immunology Laboratory, Hôpital E. Herriot-Hospices Civils de Lyon, 5 place d’Arsonval, 69437 Lyon, France
1 shared publication
Latest Publications
- Open Access
- 3 November 2022
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 29 (2) , 94.e1-94.e13
Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation
- 3 November 2022
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 29 (2) , 94.e1-94.e13
Open AccessDistinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation
- Open Access
- 27 March 2022
- Published by Elsevier in EBioMedicine
- Vol. 78, 103967
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19
- 27 March 2022
- Published by Elsevier in EBioMedicine
- Vol. 78, 103967
Open AccessT cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19